U.S. markets open in 6 hours 31 minutes

Landos Biopharma, Inc. (LABP)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
10.06-0.79 (-7.28%)
At close: 4:00PM EDT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
Total Revenue
0
0
0
0
Operating Expense
30,676
30,676
13,290
5,934
Operating Income
-30,676
-30,676
-13,290
-5,934
Net Non Operating Interest Income Expense
455
455
-304
-4
Other Income Expense
77
77
127
-106
Pretax Income
-30,144
-30,144
-13,467
-6,044
Net Income Common Stockholders
-30,144
-30,144
-13,467
-6,044
Diluted NI Available to Com Stockholders
-30,144
-30,144
-13,467
-6,044
Basic EPS
-
-
-0.58
-0.26
Diluted EPS
-
-
-0.58
-0.26
Basic Average Shares
-
-
23,103
23,103
Diluted Average Shares
-
-
23,103
23,103
Total Operating Income as Reported
-30,676
-30,676
-13,290
-7,939
Total Expenses
30,676
30,676
13,290
5,934
Net Income from Continuing & Discontinued Operation
-30,144
-30,144
-13,467
-6,044
Normalized Income
-30,221
-30,221
-13,434
-5,938
Interest Income
455
455
-
-
Interest Expense
0
0
304
4
Net Interest Income
455
455
-304
-4
EBIT
-30,144
-30,144
-13,163
-6,040
EBITDA
-30,007
-
-
-
Reconciled Depreciation
137
137
103
80
Net Income from Continuing Operation Net Minority Interest
-30,144
-30,144
-13,467
-6,044
Total Unusual Items Excluding Goodwill
77
77
-33
-106
Total Unusual Items
77
77
-33
-106
Normalized EBITDA
-30,084
-30,084
-13,027
-5,854
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0